László Ötvös

6.5k total citations
169 papers, 5.3k citations indexed

About

László Ötvös is a scholar working on Molecular Biology, Microbiology and Organic Chemistry. According to data from OpenAlex, László Ötvös has authored 169 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 41 papers in Microbiology and 36 papers in Organic Chemistry. Recurrent topics in László Ötvös's work include Antimicrobial Peptides and Activities (41 papers), DNA and Nucleic Acid Chemistry (27 papers) and Chemical Synthesis and Analysis (25 papers). László Ötvös is often cited by papers focused on Antimicrobial Peptides and Activities (41 papers), DNA and Nucleic Acid Chemistry (27 papers) and Chemical Synthesis and Analysis (25 papers). László Ötvös collaborates with scholars based in Hungary, United States and Australia. László Ötvös's co-authors include John D. Wade, Ralf Hoffmann, Sándor Lovas, Barry A. Condie, János Sági, David J. Craik, Goran Kragol, Eva Surmacz, Marco Cassone and Philippe Bulet and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

László Ötvös

166 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Ötvös Hungary 39 3.1k 1.9k 736 657 652 169 5.3k
Luís Rivas Spain 43 1.8k 0.6× 1.5k 0.8× 1.0k 1.4× 710 1.1× 1.3k 1.9× 160 5.4k
David W. Hoskin Canada 46 3.9k 1.3× 1.8k 1.0× 2.1k 2.9× 430 0.7× 358 0.5× 196 7.9k
Daniel Knappe Germany 28 1.7k 0.5× 1.5k 0.8× 328 0.4× 160 0.2× 251 0.4× 63 2.5k
Kalyan Mitra India 35 1.4k 0.5× 366 0.2× 460 0.6× 360 0.5× 489 0.8× 143 3.9k
Wojciech Kamysz Poland 42 2.7k 0.9× 2.1k 1.1× 566 0.8× 608 0.9× 316 0.5× 225 5.8k
E. Lederer France 52 3.9k 1.3× 811 0.4× 1.9k 2.5× 1.4k 2.1× 1.7k 2.6× 264 8.8k
Peter Elsbach United States 52 3.4k 1.1× 2.2k 1.2× 3.4k 4.6× 122 0.2× 666 1.0× 135 7.4k
Artur J. Ulmer Germany 36 1.6k 0.5× 735 0.4× 2.8k 3.7× 330 0.5× 815 1.3× 77 5.3k
Robert A. Nicholas United States 44 2.5k 0.8× 2.1k 1.1× 246 0.3× 239 0.4× 674 1.0× 137 6.7k
Lee Whitmore United Kingdom 13 3.5k 1.1× 447 0.2× 263 0.4× 325 0.5× 213 0.3× 21 5.3k

Countries citing papers authored by László Ötvös

Since Specialization
Citations

This map shows the geographic impact of László Ötvös's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Ötvös with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Ötvös more than expected).

Fields of papers citing papers by László Ötvös

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Ötvös. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Ötvös. The network helps show where László Ötvös may publish in the future.

Co-authorship network of co-authors of László Ötvös

This figure shows the co-authorship network connecting the top 25 collaborators of László Ötvös. A scholar is included among the top collaborators of László Ötvös based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Ötvös. László Ötvös is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ötvös, László. (2025). The potential of classical antibacterial peptides in mammalian antiviral chemotherapy. Australian Journal of Chemistry. 78(11).
2.
Ötvös, László & John D. Wade. (2023). Big peptide drugs in a small molecule world. Frontiers in Chemistry. 11. 1302169–1302169. 17 indexed citations
3.
Kraus, Carl, et al.. (2022). Functional Effects of ARV-1502 Analogs Against Bacterial Hsp70 and Implications for Antimicrobial Activity. Frontiers in Chemistry. 10. 798006–798006. 5 indexed citations
4.
Ötvös, László. (2019). Potential Leptin Receptor Response Modifier Peptides. Australian Journal of Chemistry. 73(4). 264–270. 2 indexed citations
5.
Ostorházi, Eszter, Andrea Horváth, Dóra Szabó, & László Ötvös. (2017). Transdermally administered proline–arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model. Amino Acids. 49(9). 1647–1651. 10 indexed citations
6.
Surmacz, Eva & László Ötvös. (2015). Molecular targeting of obesity pathways in cancer. Hormone Molecular Biology and Clinical Investigation. 22(2). 53–62. 20 indexed citations
7.
Li, Wenyi, Neil M. O’Brien‐Simpson, Julien Tailhades, et al.. (2015). Multimerization of a Proline-Rich Antimicrobial Peptide, Chex-Arg20, Alters Its Mechanism of Interaction with the Escherichia coli Membrane. Chemistry & Biology. 22(9). 1250–1258. 60 indexed citations
8.
You, Zhi‐Bing, et al.. (2015). Reciprocal Inhibitory Interactions Between the Reward-Related Effects of Leptin and Cocaine. Neuropsychopharmacology. 41(4). 1024–1033. 34 indexed citations
9.
Knappe, Daniel, Marco Cassone, Friederike I. Nollmann, László Ötvös, & Ralf Hoffmann. (2014). Hydroxyproline Substitutions Stabilize Non-Glycosylated Drosocin Against Serum Proteases Without Challenging its Antibacterial Activity. Protein and Peptide Letters. 21(4). 321–329. 10 indexed citations
10.
Ötvös, László, Eva Regina Haspinger, Francesca La Russa, et al.. (2011). Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnology. 11(1). 90–90. 149 indexed citations
11.
Ostorházi, Eszter, Ferenc Rozgonyi, Dóra Szabó, et al.. (2010). Intramuscularly administered peptide A3‐APO is effective against carbapenem‐resistant Acinetobacter baumannii in mouse models of systemic infections. Biopolymers. 96(2). 126–129. 24 indexed citations
12.
Ötvös, László, Marco Cassone, Marianna Terrasi, et al.. (2009). Agonists and Partial Antagonists Acting on the Leptin—Leptin Receptor Interface. Advances in experimental medicine and biology. 611. 497–498. 7 indexed citations
13.
Ötvös, László. (2005). Antibacterial peptides and proteins with multiple cellular targets. Journal of Peptide Science. 11(11). 697–706. 133 indexed citations
14.
Kragol, Goran, et al.. (2001). Synthesis of a disulfide-linked octameric peptide construct carrying three different antigenic determinants. Bioorganic & Medicinal Chemistry Letters. 11(11). 1417–1420. 5 indexed citations
15.
Čudić, Mare, Philippe Bulet, Ralf Hoffmann, David J. Craik, & László Ötvös. (1999). Chemical synthesis, antibacterial activity and conformation of diptericin, an 82‐mer peptide originally isolated from insects. European Journal of Biochemistry. 266(2). 549–558. 49 indexed citations
16.
Kralovánszky, Judit, András Jeney, Paul Noordhuis, et al.. (1999). 5-Ethyl-2′-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil. Journal of Cancer Research and Clinical Oncology. 125(12). 675–684. 7 indexed citations
17.
Ötvös, László, et al.. (1999). Enzymatic Hydrolysis and Biological Activity of Oligonucleotides Containing 5-Substituted Pyrrmidine Bases. Nucleosides and Nucleotides. 18(6-7). 1665–1666. 8 indexed citations
18.
Ertl, Hildegund C.J., Bernhard Dietzschold, & László Ötvös. (1991). T helper cell epitope of rabies virus nucleoprotein defined by tri‐ and tetrapeptides. European Journal of Immunology. 21(1). 1–10. 34 indexed citations
19.
Trojanowski, John Q., Maria Luiza Gava Schmidt, László Ötvös, et al.. (1989). Selective Expression of Epitopes in Multiphosphorylation Repeats of the High and Middle Molecular Weight Neurofilament Proteins in Alzheimer Neurofibrillary Tangles. Annals of Medicine. 21(2). 113–116. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026